Additionally, Yang et al. demonstrated that miR-214 increased the ovarian cancer cells (e.g., HIOSE-80, MCC-3, A2780S, and OV119) resistance to cisplatin, by targeting PTEN, which in turn activated the PI3K-Akt pathway and further increased ovarian cancer cell proliferation [82]. The gene discussed is PTEN; the disease is ovarian cancer.